Adult-derived human liver stem/progenitor cells (ADHLSCs) are, nowadays, developed as therapeutic medicinal product for the treatment of liver defects. In this study, the impact of hepatogenic differentiation and inflammation priming on the ADHLSCs' immune profile was assessed in vitro and compared to that of mature hepatocytes. The constitutive immunological profile of ADHLSCs was greatly different from that of hepatocytes. Differences in the expression of the stromal markers CD90 and CD105, adhesion molecules CD44 and CD49e, immunoregulatory molecules CD73 and HO-1, and NK ligands CD112 and CD155 were noted. While they globally preserved their immunological profile in comparison to undifferentiated counterparts, differentiated ADHLSCs showed a significant downregulation of CD200 expression as in hepatocytes. This was mainly induced by signals issued from EGF and OSM. On the other hand, the impact of inflammation was quite similar for all studied cell populations with an increased expression level of CD54 and CD106 and induction of that of CD40 and CD274. In conclusion, our immune profiling study suggests CD200 as a key factor in regulating the immunobiology of differentiated ADHLSCs. A better understanding of the molecular and physiological events related to such marker could help in designing the optimal conditions for an efficient therapeutic use of ADHLSCs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405586PMC
http://dx.doi.org/10.1155/2017/2679518DOI Listing

Publication Analysis

Top Keywords

adult-derived human
8
human liver
8
liver stem/progenitor
8
stem/progenitor cells
8
impact hepatogenic
8
hepatogenic differentiation
8
differentiation inflammation
8
immunological profile
8
differentiated adhlscs
8
adhlscs
5

Similar Publications

Tooth/skeletal dysplasia, such as hypophosphatasia (HPP), has been extensively studied. However, there are few definitive treatments for these diseases owing to the lack of an in vitro disease model. Cells differentiated from patient-derived induced pluripotent stem cells (iPSCs) demonstrate a pathological phenotype.

View Article and Find Full Text PDF

Adult-based genetic risk scores for insulin resistance associate with cardiometabolic traits in children and adolescents.

J Clin Endocrinol Metab

December 2024

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.

Article Synopsis
  • Insulin resistance is a crucial factor in developing cardiometabolic diseases, and while genetic risk scores for it have been validated in adults, their applicability to youth is uncertain.
  • A study involving children and adolescents with and without obesity evaluated adult-derived genetic risk scores (GRSs) for insulin resistance, showing significant associations with various cardiometabolic traits.
  • The findings indicate that these GRSs could help assess insulin resistance-related cardiometabolic risk in youth if further validated in future studies.
View Article and Find Full Text PDF
Article Synopsis
  • - Thrombocytopenia in preterm newborns can lead to increased bleeding risk, and recent findings suggest that using adult-derived platelet transfusions may be harmful due to developmental mismatches; hence there's interest in using cord blood-derived platelet concentrates (CBPCs) as a safer alternative.
  • - The study conducted various methods to produce CBPCs from cord blood collected after near-term and full-term pregnancies and compared these to adult-derived platelet concentrates (PCs) in terms of quality parameters during storage.
  • - Results showed that while CBPCs were generally comparable to control PCs, they exhibited lower pH and platelet concentration along with elevated apoptosis markers, indicating a need for improved processing and storage practices for low-volume platelets.
View Article and Find Full Text PDF

Sex differences and age-related changes in the human heart at the tissue, cell, and molecular level have been well-documented and many may be relevant for cardiovascular disease. However, how molecular programs within individual cell types vary across individuals by age and sex remains poorly characterized. To better understand this variation, we performed single-nucleus combinatorial indexing (sci) ATAC- and RNA-Seq in human heart samples from nine donors.

View Article and Find Full Text PDF
Article Synopsis
  • HSCs play a key role in liver fibrosis, while adult-derived human liver stem/progenitor cells (ADHLSCs) show potential for treatment due to their higher differentiation and proliferation abilities.
  • The study utilized a dataset to compare gene expression differences between ADHLSCs and HSCs, aiming to uncover new therapeutic targets for liver fibrosis.
  • Findings revealed 332 down-regulated and 201 up-regulated genes, with MEOX2 identified as a critical factor that inhibits HSC proliferation through the PI3K/AKT signaling pathway, suggesting it could be a promising target for LF treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!